Bill Pagels, Phd Email & Phone Number

Carlsbad, Ca, Us

ACTT Med is a portable device that works via transdermal pads on the skin or by sitting or lying on a grounding sheet or pad that increase vibrational energy. It is imperceptible and can be used safely while sleeping or being active. ACTT Med is not FDA approved and is used only for experimental purposes. See disclaimer.Two main processes occur at the cellular level during exposure to ACTT Med's alternating current: diseased proliferation is halted, and excessively dividing cells are destroyed. This gives your body's previously overwhelmed immune system a chance to mount a proper defense or recover with supplemental medicinal treatment.The electrical charge has the ability to disrupt proliferating cells, and the cell division process, inhibiting the multiplication of diseased cells. A similar technology has been used for many years with no known safety issues or adverse side effects.The ACTT Med device delivers a high frequency, very low amperage, low wattage, low voltage charge. A similar FDA certified, high frequency, alternating current device has already been approved for use in the treatment of two types of cancers.

Reliable-LFC is the sole rapid antigen test winner of the coveted and recent XPRIZE Foundation's RapidCOVID competition with >700 competitors from 38 countries. Although not currently available in the US, Reliable sells its rapid, inexpensive, easy to use tests internationally with the focus of contributing to curtailing the pandemic.Reliable-LFC has won a contract with the U.S. Air Force interested in Reliable's platform technology to diagnose and stratify patients with neurological trauma associated with multiple diseases including TBI (Traumatic Brain Injury), Parkinson's Disease, ALT, Alzheimer's Disease and potentially CTE (Chronic Traumatic Encephalopathy). As a platform diagnostic technology, ultra-high sensitivity analyses are possible for other disease states and Reliable has demonstrated feasibility for detecting COVID, heart attacks, inflammation from cancer, and these neurological disorders.

Salt Lake City, Ut, Us

ApolloDx develops its mobile IVD platform for real-time detection, tracking and trending of infectious diseases and bio-threat agents. ApolloDx’s Mobile IVD Platform is an easy-to-use, smartdevice-based, inexpensive system that provides and transmits geotagged laboratory-quality results to remote servers in real-time. The bidirectional data transmission, integration and real-time analytics enable high-quality decisions based on objective results, as well as data tracking and trending that can be securely viewed by other parties.

Consulting to the State of Utah Centers of Excellence Program to drive technologies from research laboratories to market. Public and private clients in biotechnology (microarrays), medical devices (needle stick injury protection), medical diagnostics (appendicitis testing), HIV diagnostics, and nanotechnology.

Salt Lake City, Ut, Us

Food safety diagnostics and therapeutics

3PDx developed a broadly applicable platform technology that both to decentralize many tests that are traditionally performed in central laboratories by trained technicians. The market segments for 3PDx's simple test format are laypeople, physician offices, clinics, etc. without the training, time or inclination to routinely conduct rigorous, technical procedures.

4M assists small- and mid-sized companies prepare for a funding event in order to extract the full value of their technology/expertise. We address the needs of companies in industries as diverse as the life sciences, medical devices, web-based education, IT, consumer goods and energy.

Depoe Bay, Or, Us

Grow offers unmatched expertise in helping innovative firms obtain R&D funding from the federal government. Grow's co-founder, Mark Henry, is the foremost SBIR/STTR grant writing advisor in the country having participated in submitting >2000 grant proposals over the past almost 30 years. Mark's success in obtaining funding for clients is, for Phase I and Phase II respectively, 5-times and 2-times the national average. Grow assists clients in securing government contracts too. Grow's last two government contract clients received notices of allowance for $112MIL in funding.

H.M. Pharma Consultancy is a new type of solution provider for the life science industry -- a data-driven knowledge foundry in the service of pharmaceutical and medical business development. With deep scientific expertise, advanced data retrieval modalities, and cutting edge knowledge management, the company specializes in, among other areas, strategic patenting - drilling deep within intellectual patent domains to exploit unclaimed territory for clients' benefit. Scientific areas of particular strength include: ophthalmology (pharmaceuticals and surgical procedures), cardiorespiratory medicine (hypertension and imaging), central/peripheral nervous system (psychiatry and neurology), urology and viral infection.

Abbott Park, Illinois, Us

Directed biological, chemical and microbiological test development and evaluation of Abbott's/Hospira's medical devices high volume manufacturing operations.

Us

Led commercial development and market introduction of the first-of-kind microarray sample mixing system called "MAUI" establishing a customer base leading to the eventual acquisition by Roche.

Directed all business development, marketing, clinical affairs, regulatory affairs, QA, product management and corporate communications.Forty person diagnostics company with leading platform for rapid, pseudohomogeneous diagnostics applicable to cardiovascular events, military warfare agents, environmental/agricultural diagnostics, veterinary diagnostics and life sciences research.Technology received the coveted R&D 100 Award for country's top high tech technology of the year.

Marlborough, Ma, Us

Managed $350MIL domestic / $450MIL international product lines including cardiovascular grafts, cardiovascular fabrics and hernia products.

New Brunswick, Nj, Us

Developer of the first-of-kind OTC HIV Test Blood Collection kit, called "Confide". Received PMA approval from FDA in 1996.Multiple patent applications.Initiated development of next generation saliva-based HIV testing devices.

New Brunswick, Nj, Us

Developed and commercialized multiplicity of IVD systems and assays for infectious disease testing. Market focus: blood bank testing industry.

Developed clinical and infectious disease diagnostic tests including the first-of-kind rapid, equipment-free, market-leading test, HIVCHEK(tm). HIVCHEK received distinction as one of the best technologies of the year, the IR100 Award, in 1989.

Phd, Biochemistry

Masters Studies In Chemistry

Ba, Sociology